Cibc Asset Management Inc Amgen Inc Transaction History

Cibc Asset Management Inc

$28.3 Billion
Q3 2024

A detailed history of Cibc Asset Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Cibc Asset Management Inc holds 335,212 shares of AMGN stock, worth $98.7 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

335,212

Previous 319,078 5.06%

Holding current value

$98.7 Million

Previous $99.7 Million 8.34%

% of portfolio

0.38%

Previous 0.38%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$309.38 - $337.38 $4.99 Million - $5.44 Million	16,134 Added 5.06%	335,212 $108 Million
Q2 2024 Aug 01, 2024	SELL	$262.75 - $319.31 $5.52 Million - $6.71 Million	-21,027 Reduced 6.18%	319,078 $99.7 Million
Q1 2024 May 09, 2024	BUY	$268.87 - $324.56 $1.97 Million - $2.38 Million	7,341 Added 2.21%	340,105 $96.7 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $6.89 Million - $7.78 Million	-26,963 Reduced 7.5%	332,764 $95.8 Million
Q3 2023 Oct 30, 2023	BUY	$218.65 - $271.46 $379,357 - $470,983	1,735 Added 0.48%	359,727 $96.7 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $5.28 Million - $6.24 Million	24,624 Added 7.39%	357,992 $79.5 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $1.35 Million - $1.64 Million	5,958 Added 1.82%	333,368 $80.6 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $2.97 Million - $3.78 Million	-12,974 Reduced 3.81%	327,410 $86 Million
Q3 2022 Nov 03, 2022	BUY	$224.46 - $253.15 $25.3 Million - $28.5 Million	112,764 Added 49.54%	340,384 $76.7 Million
Q2 2022 Aug 09, 2022	BUY	$230.71 - $256.74 $14 Million - $15.6 Million	60,862 Added 36.5%	227,620 $55.4 Million
Q1 2022 May 06, 2022	BUY	$219.27 - $242.57 $8.93 Million - $9.87 Million	40,708 Added 32.3%	166,758 $40.3 Million
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $4.89 Million - $5.6 Million	-24,587 Reduced 16.32%	126,050 $28.4 Million
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $910,638 - $1.07 Million	4,290 Added 2.93%	150,637 $32 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $615,249 - $682,574	2,634 Added 1.83%	146,347 $35.7 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $7.2 Million - $8.39 Million	32,443 Added 29.16%	143,713 $35.8 Million
Q4 2020 Feb 03, 2021	BUY	$216.38 - $257.67 $990,587 - $1.18 Million	4,578 Added 4.29%	111,270 $25.6 Million
Q3 2020 Nov 05, 2020	SELL	$234.65 - $260.95 $4.36 Million - $4.84 Million	-18,563 Reduced 14.82%	106,692 $27.1 Million
Q2 2020 Jul 28, 2020	BUY	$197.81 - $242.74 $5.63 Million - $6.91 Million	28,459 Added 29.4%	125,255 $29.5 Million
Q1 2020 Apr 30, 2020	BUY	$182.24 - $241.7 $472,912 - $627,211	2,595 Added 2.75%	96,796 $19.6 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $1.27 Million - $1.64 Million	6,736 Added 7.7%	94,201 $22.7 Million
Q3 2019 Oct 30, 2019	SELL	$174.11 - $208.62 $117,698 - $141,027	-676 Reduced 0.77%	87,465 $16.9 Million
Q2 2019 Aug 05, 2019	BUY	$166.7 - $195.41 $6,501 - $7,620	39 Added 0.04%	88,141 $16.2 Million
Q1 2019 May 06, 2019	SELL	$180.87 - $203.88 $126,428 - $142,512	-699 Reduced 0.79%	88,102 $16.7 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $145,039 - $169,307	813 Added 0.92%	88,801 $17.3 Million
Q3 2018 Nov 02, 2018	BUY	$185.29 - $208.89 $49,287 - $55,564	266 Added 0.3%	87,988 $18.2 Million
Q2 2018 Aug 09, 2018	BUY	$166.05 - $186.51 $220,846 - $248,058	1,330 Added 1.54%	87,722 $16.2 Million
Q1 2018 Apr 30, 2018	SELL	$169.43 - $198.0 $678,397 - $792,792	-4,004 Reduced 4.43%	86,392 $14.7 Million
Q4 2017 Feb 02, 2018	BUY	$168.79 - $188.59 $129,293 - $144,459	766 Added 0.85%	90,396 $15.7 Million
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $15 Million - $17.1 Million	89,630	89,630 $16.7 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Account

Cibc Asset Management Inc Amgen Inc Transaction History